首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1663916

藥物濫用檢測市場規模、佔有率、成長分析，按產品類型、按樣品類型、按應用、按最終用戶、按地區 - 行業預測，2025 年至 2032 年

Drug of Abuse Testing Market Size, Share, and Growth Analysis, By Product Type (Analyzers, Rapid Testing Devices), By Sample Type (Saliva, Breath), By Application, By End-user, By Region - Industry Forecast 2025-2032

出版日期: 2025年02月24日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年全球藥物濫用檢測市場規模價值 38 億美元，預計將從 2024 年的 40.2 億美元成長到 2032 年的 63.1 億美元，預測期內（2025-2032 年）的複合年成長率為 5.8%。

全球藥物濫用檢測市場正在經歷強勁成長，推動因素包括藥物濫用發生率上升、行業法規越來越嚴格以及對醫療保健和職場藥物檢測重要性的認知不斷提高。聯合國聯合國毒品犯罪防制署公佈了一個驚人的數字：非法藥物使用率每年達到 5.3%，相當於全球有 2.55 億使用者，這凸顯了對有效檢測解決方案的需求。政府為提高人們對藥物濫用的認知和遵守規定而採取的舉措以及嚴格的監管措施進一步刺激了市場需求。然而，檢測微量物質的限制以及不斷發展的娛樂性藥物合法化法律的影響等挑戰可能會阻礙進展。然而，免疫分析和分子診斷等檢測技術的進步以及口腔液體檢測的日益成長的趨勢為該行業提供了巨大的成長機會。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前 5 家公司對比
主要企業市場定位（2024年）
主要市場參與者所採用的策略
近期市場趨勢
公司市場佔有率分析（2024 年）
主要企業簡介
- 公司詳細資訊
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

Abbott Laboratories（US）
Thermo Fisher Scientific Inc.（US）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
Quest Diagnostics Incorporated（US）
Bio-Rad Laboratories, Inc.（US）
Dragerwerk AG & Co. KGaA（Germany）
Biomerieux SA（France）
Shimadzu Corporation（Japan）
Randox Laboratories Ltd.（United Kingdom）
Psychemedics Corporation（US）
Sonic Healthcare（Australia）
Merck KGaA（Germany）
LabCorp（US）
MP Biomedicals LLC（US）
Omega Laboratories, Inc.（US）
Express Diagnostics International Inc.（US）
Sciteck, Inc.（US）

結論和建議

簡介目錄

Product Code: SQMIG35H2250

Global Drug of Abuse Testing Market size was valued at USD 3.8 billion in 2023 and is poised to grow from USD 4.02 billion in 2024 to USD 6.31 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The global drug of abuse testing market is witnessing robust growth, fueled by factors such as the rising incidence of substance abuse, stringent industry regulations, and heightened awareness of drug testing's significance in healthcare and workplaces. The United Nations Office on Drugs and Crime highlights an alarming 5.3% annual prevalence of illicit drug use, equating to 255 million users globally, intensifying the need for effective testing solutions. Government initiatives promoting drug abuse awareness and compliance, alongside strict regulations, further bolster market demand. However, challenges such as limitations in detecting trace substances and the impact of evolving legalization laws for recreational drugs may hinder progress. Nevertheless, advancements in testing technologies, including immunoassays and molecular diagnostics, as well as the growing inclination towards oral fluid testing, present substantial growth opportunities in this sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Of Abuse Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Of Abuse Testing Market Segments Analysis

Global Drug of Abuse Testing Market is segmented by Product Type, Sample Type, Testing Type, End-user and region. Based on Product Type, the market is segmented into Analyzers, Rapid Testing Devices and Consumables. Based on Sample Type, the market is segmented into Saliva, Breath, Urine, Blood and Hair & Sweat. Based on Application, the market is segmented into Medical Screening, Monitoring Pain Management, Forensic & Legal Information, Employment Drug Testing, Sports & Athletics Testing. Based on End-user, the market is segmented into Hospitals, Diagnostics Laboratories, On-the-spot Testing and Forensic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Of Abuse Testing Market

The Global Drug of Abuse (DoA) Testing market is poised for significant growth, driven by an increase in the production, consumption, and trafficking of both new and illicit drugs. The World Drug Report 2017 from the United Nations Office on Drugs and Crime highlighted a 5.3% prevalence rate of illicit drug use, translating to around 255 million users by 2015. This alarming statistic emphasizes the pressing need for effective DoA testing solutions, propelling market demand. Furthermore, government initiatives aimed at spreading awareness about drug abuse and ensuring compliance with testing protocols will enhance market expansion, along with the rising preference for testing products that provide superior specificity and sensitivity for detecting designer drugs.

Restraints in the Global Drug Of Abuse Testing Market

The Global Drug of Abuse (DOA) Testing market may encounter several obstacles that could hinder its growth. One significant challenge is the current testing products' inability to effectively detect trace amounts of certain drugs. Moreover, the ongoing changes in legislation aimed at legalizing recreational or illicit substances are anticipated to further complicate market dynamics during the 2023-2030 forecast period. The associated report on the DOA testing market offers extensive insights into recent advancements, trade regulations, production analysis, value chain enhancements, and the influence of local market participants. Additionally, it highlights emerging opportunities, regulatory shifts, market sizes, product innovations, and geographic expansions, providing a comprehensive overview for stakeholders. For in-depth insights, Data Bridge Market Research can provide tailored assistance to navigate these challenges and capitalize on growth opportunities.

Market Trends of the Global Drug Of Abuse Testing Market

The Global Drug of Abuse Testing market is witnessing a significant shift towards point-of-care testing, a trend fueled by an increasing demand for rapid, on-site results that cater to diverse healthcare settings, including remote and decentralized locations. This innovation enhances accessibility for healthcare providers, improves patient management, and addresses the urgent need for timely decision-making in substance abuse cases. The rise of point-of-care testing is further supported by advancements in technology and diagnostic tools, aligning with the broader healthcare movement towards more patient-centered approaches. As a result, this trend is reshaping service delivery and expanding market opportunities in the drug testing sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Drug of Abuse Testing Market Size by Product Type & CAGR (2025-2032)

Market Overview
Analyzers
- Immunoassays Analyzers
- Chromatographic Devices
- Breath Analyzers
Rapid Testing Devices
- Urine Testing Devices
- Oral Fluid Testing Devices
Consumables
- Fluid Collection Devices
- Others

Global Drug of Abuse Testing Market Size by Sample Type & CAGR (2025-2032)

Market Overview
Saliva
Breath
Urine
Blood
Hair & Sweat

Global Drug of Abuse Testing Market Size by Application & CAGR (2025-2032)

Market Overview
Medical Screening
Monitoring Pain Management
Forensic & Legal Information
Employment Drug Testing
Sports & Athletics Testing

Global Drug of Abuse Testing Market Size by End-user & CAGR (2025-2032)

Market Overview
Hospitals
Diagnostics Laboratories
On-the-spot Testing
Forensic Laboratories

Global Drug of Abuse Testing Market Size & CAGR (2025-2032)

North America (Product Type, Sample Type, Application, End-user)
- US
- Canada
Europe (Product Type, Sample Type, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Sample Type, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Sample Type, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Sample Type, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psychemedics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonic Healthcare (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabCorp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MP Biomedicals LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Express Diagnostics International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciteck, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments